Komori
StemRIM (4599) · RiskRestated

Dependence on joint research and license agreements with Osaka University

First written in FY2020. 3 of 5 entries say "Restated". Latest entry: FY2025.

5entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2020 – FY2022WorsenedFY2023RestatedFY2024 – FY20252020: 12021: 020212022: 120222023: 120232024: 120242025: 12025
Same theme, other companies
Risk of dependence on joint R&D counterparties and termination of agreementsA theme 16 companies write about · 19 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2020: 2 of 6 companies on the "Worse" side.

4 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 16 companies compared. The sentences above are computed from all 16.
Full recordFilings, disclosures and news, newest first
  1. FY2025RestatedAnnual report

    「However, if renewing these agreements becomes difficult for any reason, or if transactions become difficult due to termination or other circumstances, this may have a significant impact on the Company's business development.」

    Dependence on contractual relationships with Osaka University, including joint research, licenses and collaborative research laboratories, as well as the risks of difficulty renewing or terminating these agreements, have been reconfirmed.
  2. FY2024RestatedAnnual report

    「However, if renewing these agreements becomes difficult for any reason, or if transactions become difficult due to termination or other circumstances, this may have a significant impact on the Company's business development.」

    Dependence on contractual relationships with Osaka University, including joint research, licenses and collaborative research laboratories, as well as the risks of difficulty renewing or terminating these agreements, have been reconfirmed.
  3. FY2023WorsenedAnnual report

    「In transactions with the university, while maintaining a good relationship, we are exercising due care to comply with laws and regulations and through oversight by the Board of Directors, so as not to harm the interests of the Company or its shareholders. However, notwithstanding these precautions, if a situation arises in which the transactions are suspected of constituting the provision of benefits, this may damage the Company's interests and social reputation, and consequently adversely affect its business, operating results and financial position.」

    In addition to the risk of dependence on joint research and agreements with Osaka University, compliance and reputational risks have been explicitly identified, including adverse effects on the Company's interests and social reputation if transactions are suspected of constituting the provision of benefits.
  4. FY2022RestatedAnnual report

    「If renewing these agreements becomes difficult for any reason, or if transactions become difficult due to termination or other circumstances, this may have a significant impact on the Company's business development.」

    Dependence on contractual relationships with Osaka University, including joint research, licenses and collaborative research laboratories, as well as the risks of difficulty renewing or terminating these agreements, have been reconfirmed.
  5. FY2020First statedAnnual report

    「However, if renewing these agreements becomes difficult for any reason, or if transactions become difficult due to termination or other circumstances, this may have a significant impact on the Company's business development.」

    Newly organized risks include the termination or inability to renew contractual relationships involving joint research with Osaka University, exclusive rights to shared patents and collaborative research laboratories.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for StemRIM yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Dependence on joint research and license agreements with Osaka University | StemRIM Inc. (4599) | Komori